PMID- 23992656
OWN - NLM
STAT- MEDLINE
DCOM- 20150120
LR  - 20151119
IS  - 1532-8422 (Electronic)
IS  - 1053-0770 (Linking)
VI  - 28
IP  - 3
DP  - 2014 Jun
TI  - Comparison of pulmonary complications in patients undergoing transcatheter aortic 
      valve implantation versus open aortic valve replacement.
PG  - 497-501
LID - S1053-0770(13)00230-9 [pii]
LID - 10.1053/j.jvca.2013.04.006 [doi]
AB  - OBJECTIVE: The purpose of this study was to investigate and compare the 
      differences in postoperative pulmonary complications in patients undergoing 
      aortic valve replacement by open repair (OAVR) versus those undergoing 
      transcatheter aortic valve implantation by the transapical approach (TAVI-A) or 
      transfemoral approach (TAVI-F). DESIGN: A retrospective review of data from 
      aortic valve replacement patients. SETTING: A private, non-profit hospital. 
      PARTICIPANTS: Thirty patients with severe aortic stenosis requiring surgical 
      replacement. INTERVENTIONS: Data collected from TAVI-F, TAVI-A, and OAVR patient 
      charts. MATERIALS AND METHODS: Patients were divided into 3 groups: 10 patients 
      undergoing OAVR, 10 patients undergoing TAVI-F, and 10 patients undergoing 
      TAVI-A. Pulmonary complications and length of stay were recorded and analyzed. 
      The TAVI-F group had the lowest number of total pulmonary complications per 
      patient (1.0+/-0.667) compared to the OAVR group (1.8+/-0.789, p = 0.04) and TAVI-A 
      group (2.0+/-1.054, p = 0.02). The most frequent complication was atelectasis. 
      TAVI-F patients spent the least amount of time on the ventilator (TAVI-F median 
      2.6, IQR 4.8 h, TAVI-A median 4.9, IQR 7.6 h, and OAVR median 6.6, IQR 17.3 h, p 
      = 0.02) and were discharged in half the time of the other groups (TAVI-F median 
      3.2, IQR 1.3 days, TAVI-A median 5.6, IQR 3.5 days, OAVR median 6.1, IQR 4.6 
      days, p = 0.008). CONCLUSIONS: Due to the high incidence of multiple 
      comorbidities and increased age, it is important to take into consideration the 
      risk of pulmonary complications when choosing the surgical and anesthetic 
      approach to TAVI in this high-risk group of patients.
CI  - Copyright (c) 2014 Elsevier Inc. All rights reserved.
FAU - Pettet, Jamie K
AU  - Pettet JK
AD  - Department of Anesthesia, Parkwest Medical Center, Knoxville, TN. Electronic 
      address: Jpettet1@gmail.com.
FAU - McGhee, Myra N
AU  - McGhee MN
AD  - Department of Anesthesia, Parkwest Medical Center, Knoxville, TN.
FAU - McIlrath, S Timothy
AU  - McIlrath ST
AD  - Department of Anesthesia, Parkwest Medical Center, Knoxville, TN.
FAU - Collins, Gordon L
AU  - Collins GL
AD  - Department of Anesthesia, Parkwest Medical Center, Knoxville, TN.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20130828
PL  - United States
TA  - J Cardiothorac Vasc Anesth
JT  - Journal of cardiothoracic and vascular anesthesia
JID - 9110208
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Aortic Valve/*surgery
MH  - Cardiac Catheterization/*adverse effects
MH  - Critical Care/statistics & numerical data
MH  - Female
MH  - Heart Valve Prosthesis Implantation/*adverse effects
MH  - Hospital Mortality
MH  - Humans
MH  - Lung Diseases/*epidemiology/etiology
MH  - Male
MH  - Postoperative Complications/*epidemiology
MH  - Retrospective Studies
OTO - NOTNLM
OT  - anesthesia
OT  - aortic stenosis
OT  - aortic valve replacement
OT  - pulmonary complications
OT  - transcatheter aortic valve implantation
EDAT- 2013/09/03 06:00
MHDA- 2015/01/21 06:00
CRDT- 2013/09/03 06:00
PHST- 2013/02/13 00:00 [received]
PHST- 2013/09/03 06:00 [entrez]
PHST- 2013/09/03 06:00 [pubmed]
PHST- 2015/01/21 06:00 [medline]
AID - S1053-0770(13)00230-9 [pii]
AID - 10.1053/j.jvca.2013.04.006 [doi]
PST - ppublish
SO  - J Cardiothorac Vasc Anesth. 2014 Jun;28(3):497-501. doi: 
      10.1053/j.jvca.2013.04.006. Epub 2013 Aug 28.